Recent Finacing
Recent Raise
Basking Biosciences is a clinical-stage biopharmaceutical developing a reversible RNA aptamer that inhibits von Willebrand Factor for thrombolysis in acute ischemic stroke, paired with a rapid-acting oligonucleotide reversal agent.
